retatrutide clinical trial parkinson New Parkinson's Treatments in the Pipeline retatrutide parkinson's disease trial nct

In May 2024, Reuters reported more optimistic forecasts from other experts with BMO Capital expecting the weight-loss market to reach $150 billion by the early 2030s, while Leerink projects a $158 billion value by 2032

The adoption of ICHRAs and QSEHRAs has continued its steady climb, with ICHRA showing almost 30% growth from 2023 to 2024, driven largely by a sharp increase in uptake among Applicable Large Employers (ALEs) of 50 or more full-time employees

Keep a light blanket at your desk or in your car so you can adjust your insulation quickly as your comfort needs change throughout the day

F-AFE- containing anti-allergic compounds, like arctigenin, inhibits the IgE-mediated allergic pathway